反応 #168423
ord-ae126f303d11461fbc61b9ed9452e1c6
反応方程式
反応物
試薬
溶媒
反応条件
後処理
- 1その他The cooling bath was removed
- 2温度the solution warmed to room temperature
- 3workup.STIRRINGstirred for 60 minutes
- 4workup.ADDITIONThe mixture was then diluted with ethyl acetate
- 5洗浄washed with sodium thiosulfate (2×) and brine (1×)
- 6乾燥The organic layer was dried over magnesium sulfate
- 7ろ過filtered
- 8濃縮concentrated
- 9その他The resulting residue was purified via silica gel chromatography (0-100% ethyl acetate/hexanes)
実験手順
4-(5-Chloropyridin-3-yl)-3-[(trans-4-methylcyclohexyl)methyl]-2-[(3R)-3-phenylmorpholin-4-yl]-3H-imidazo[4,5-c]pyridine-6-carbonitrile (Example 2.1, Step 4; 180 mg, 0.342 mmol) was taken up in THF (3415 μl) and cooled to −78° C. Lithium magnesium 2,2,6,6-tetramethylpiperidin-1-ide dichloride (1M solution in THF/toluene, 683 μl, 0.683 mmol) was added, and the mixture was stirred at −78° C. for 45 minutes. 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione (244 mg, 0.854 mmol) was then added. The cooling bath was removed, and the solution warmed to room temperature and stirred for 60 minutes. The mixture was then diluted with ethyl acetate and washed with sodium thiosulfate (2×) and brine (1×). The organic layer was dried over magnesium sulfate, filtered, and concentrated. The resulting residue was purified via silica gel chromatography (0-100% ethyl acetate/hexanes) to afford 7-bromo-4-(5-chloropyridin-3-yl)-3-[(trans-4-methylcyclohexyl)methyl]-2-[(3R)-3-phenylmorpholin-4-yl]-3H-imidazo[4,5-c]pyridine-6-carbonitrile as a white solid that was contaminated with unreacted starting material. MS ESI calc'd. for C30H30BrClN6O [M+1]+, [M+3]+605, 607. found 605, 607.